The Potentiation of Estrogen on Insulin-like Growth Factor I Action in MCF-7 Human Breast Cancer Cells Includes Cell Cycle Components
Open Access
- 1 November 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (46) , 35893-35901
- https://doi.org/10.1074/jbc.m006741200
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Activation of the Human p27Kip1 Promoter by IFNα 2bBiochemical and Biophysical Research Communications, 2000
- FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cellsOncogene, 1998
- Insulin-like Growth Factor-1 (IGF-1) Receptor-Insulin Receptor Substrate Complexes in the UterusPublished by Elsevier ,1998
- Insulin Receptor Substrate-1 is the Predominant Signaling Molecule Activated by Insulin-like Growth Factor-I, Insulin, and Interleukin-4 in Estrogen Receptor-positive Human Breast Cancer CellsPublished by Elsevier ,1998
- Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein KinaseJournal of Biological Chemistry, 1997
- The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling PathwaysJournal of Biological Chemistry, 1997
- Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer CellsJournal of Biological Chemistry, 1996
- G1 phase progression: Cycling on cueCell, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- Type 1 IGF receptor in human breast diseasesBreast Cancer Research and Treatment, 1992